Emergent BioSolutions Inc. 4

4 · Emergent BioSolutions Inc. · Filed Nov 13, 2015

Form 4

Period: 2015-11-11

EVP, Biosciences Div.

Transactions

Exercise/Conversion
Common Stock
2015-11-11$28.09/sh+9,373$263,288→ 39,602 total
Exercise/Conversion
Common Stock
2015-11-11$20.94/sh+10,095$211,389→ 40,324 total
Sale
Common Stock
2015-11-11$35.50/sh−10,095$358,373→ 30,229 total
Exercise/Conversion
Common Stock
2015-11-12$20.94/sh+10,094$211,368→ 40,323 total
Sale
Common Stock
2015-11-12$36.00/sh−10,094$363,384→ 30,229 total
Tax Payment
Common Stock
2015-11-11$35.88/sh−1,671$59,955→ 28,558 total
Exercise/Conversion
Stock Option
2015-11-11−9,373→ 0 total
Exercise: $28.09From: 2014-03-11Exp: 2021-03-10→ Common Stock (9,373 underlying)
Exercise/Conversion
Stock Option
2015-11-11−10,095→ 0 total
Exercise: $20.94From: 2013-11-11Exp: 2020-11-11→ Common Stock (10,095 underlying)
Exercise/Conversion
Stock Option
2015-11-12−10,094→ 0 total
Exercise: $20.94From: 2013-11-11Exp: 2020-11-11→ Common Stock (10,094 underlying)
Sale
Common Stock
2015-11-11$35.51/sh−6,564$233,088→ 30,229 total
Sale
Common Stock
2015-11-11$35.50/sh−9,373$332,742→ 30,229 total

Footnotes (4)

[F1]Consists of an option granted under the company's stock incentive plan on March 11, 2014.
[F2]Consists of an option granted under the company's stock incentive plan on November 12, 2013.
[F3]Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
[F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50-$35.59, inclusive.

Documents

1 file